Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC) von Ricciuti, Biagio, Champagne, Christine, Jones, Greg, Lazarus, Tadd Scott, Adeni, Anika E., Cheng, Michael L., Oxnard, Geoffrey R., Awad, Mark M.

Volltext

Performance comparison of the methylated BCAT1 / IKZF1 ctDNA test (COLVERA) with the CEA assay for detection of recurrent colorectal cancer von Symonds, Erin L., Pedersen, Susanne Kartin, Murray, David, Byrne, Susan E, Hollington, Paul, Rabbitt, Philippa, Jones, Frederick S., Segelov, Eva, Lazarus, Tadd Scott, Lapointe, Lawrence Charles, Young, Graeme P.

Volltext